Clinical Trial Update: Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating phenethyl isothiocyanate for preventing lung cancer in people who smoke; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Phenethyl Isothiocyanate (phenethyl isothiocyanate)

Snippet

Sponsor: NYU Langone Health | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED